FDA announces process for FDA guidance documents related to COVID-19. The FDA has announced procedures, which operate within the FDA’s established good guidance practices regulations, for making available FDA guidance documents related to COVID-19. The FDA believes that these procedures will allow the FDA to rapidly disseminate its recommendations and policies related to COVID-19. The Guidance documents, will be implemented without prior comment and will be accessible on the internet from the FDA web page entitled ‘‘Coronavirus Disease 2019 (COVID–19).”
Haynes and Boone has a COVID-19 task force in place and continues to monitor the global impact of COVID-19 on various industries. For questions on the FDA’s evolving COVID-19 policies or food safety during the COVID-19 crisis, please contact Suzie Trigg or any member of the Healthcare and Life Sciences Group.